The NBCA Journal Club highlights groundbreaking research in thrombosis and thrombophilia and features a manuscript author as part of the discussion. Our next session convenes June 18, 2024 from 2-3 p.m. ET to discuss, “Antithrombin Therapy: Current State and Future Outlook,” published in Clinical and Applied Thrombosis/Hemostasis in 2023.
The discussion features the paper’s author, George M. Rodgers, III, MD, PhD, Professor of Medicine in the Division of Hematology and Hematologic Malignancies at the University of Utah School of Medicine.
Learning objectives
- Understand the genetic and acquired factors contributing to antithrombin (AT) deficiency and its implications.
- Explore current treatment strategies for managing AT deficiency.
- Identify specific patient populations and use cases where AT therapy may be considered and evaluate its potential benefits.
- Investigate advancements and future directions in research, diagnosis, and treatment approaches for AT deficiency to enhance clinical outcomes and patient care.
This event is intended for a clinical audience with an interest in thrombosis and thrombophilia.
Register
